dc.contributor.author |
Paglialunga, S. |
|
dc.contributor.author |
van Bree, B. |
|
dc.contributor.author |
Valdecantos, P. |
|
dc.contributor.author |
Amengual-Cladera, E. |
|
dc.contributor.author |
Jörgensen, J.A. |
|
dc.contributor.author |
van Beurden, D. |
|
dc.contributor.author |
den Hartog, G.J.M. |
|
dc.contributor.author |
Ouwens, D.M. |
|
dc.contributor.author |
Briedé, J.J. |
|
dc.contributor.author |
Schrauwen, P. |
|
dc.contributor.author |
Hoeks, J. |
|
dc.contributor.author |
Bosma, M. |
|
dc.date.accessioned |
2024-02-06T08:57:44Z |
|
dc.identifier.uri |
http://hdl.handle.net/11201/164539 |
|
dc.description.abstract |
[eng] Aims/hypothesis High-fat, high-sucrose diet (HF)-induced reactive oxygen species (ROS) levels are implicated in skeletal muscle insulin resistance and mitochondrial dysfunction. Here we investigated whether mitochondrial ROS sequestering can circumvent HF-induced oxidative stress; we also determined the impact of any reduced oxidative stress on muscle insulin sensitivity and mitochondrial function. Methods The Skulachev ion (plastoquinonyl decyltriphe nylphosphonium) (SkQ), a mitochondria-specific antioxidant, was used to target ROS production in C2C12 muscle cells as well as in HF-fed (16 weeks old) male C57Bl/6 mice, compared with mice on low-fat chow diet (LF) or HF alone. Oxidative stress was measured as protein carbonylation levels. Glucose tolerance tests, glucose uptake assays and insulin-stimulated signalling were determined to assess muscle insulin sensitivity. Mitochondrial function was determined by high-resolution respirometry. Results SkQ treatment reduced oxidative stress in muscle cells (−23% p<0.05), but did not improve insulin sensi tivity and glucose uptake under insulin-resistant condi tions. In HF mice, oxidative stress was elevated (56% vs LF p<0.05), an effect completely blunted by SkQ. How ever, HF and HF+SkQ mice displayed impaired glucose tolerance (AUC HF up 33%, p<0.001; HF+SkQ up 22%; p<0.01 vs LF) and disrupted skeletal muscle insulin signalling. ROS sequestering did not improve mitochondrial function. Conclusions/interpretation SkQ treatment reduced muscle mitochondrial ROS production and prevented HF-induced oxidative stress. Nonetheless, whole-body glucose toler ance, insulin-stimulated glucose uptake, muscle insulin signalling and mitochondrial function were not improved. These results suggest that HF-induced oxidative stress is not a prerequisite for the development of muscle insulin resistance. |
|
dc.format |
application/pdf |
|
dc.relation.isformatof |
Versió postprint del document publicat a: https://doi.org/10.1007/s00125-012-2626-x |
|
dc.relation.ispartof |
Diabetologia, 2012, vol. 55, p. 2759-2768 |
|
dc.subject.classification |
57 - Biologia |
|
dc.subject.classification |
Ciències de la salut |
|
dc.subject.other |
57 - Biological sciences in general |
|
dc.subject.other |
Medical sciences |
|
dc.title |
Targeting mitochondrial ROS production does not avert lipid-induced insulin resistance in muscle |
|
dc.type |
info:eu-repo/semantics/article |
|
dc.type |
info:eu-repo/semantics/acceptedVersion |
|
dc.date.updated |
2024-02-06T08:57:45Z |
|
dc.date.embargoEndDate |
info:eu-repo/date/embargoEnd/2100-01-01 |
|
dc.embargo |
2100-01-01 |
|
dc.rights.accessRights |
info:eu-repo/semantics/embargoedAccess |
|
dc.identifier.doi |
https://doi.org/10.1007/s00125-012-2626-x |
|